Hims & Hears Health (HIMS) broke its uptrend that began in August at around $42. The stock peaked at over $60, only to close ...

Eli Lilly's Mounjaro clocked in ₹80 crore in September, second only to India’s leading brand of the month, GSK’s Augmentin, ...

A real weight loss drug, called retatrutide, is currently being developed by pharmaceutical giant Eli Lilly, but there has ...

Florida-based wealth advisory J. L. Bainbridge disclosed a purchase of Eli Lilly and Company valued at approximately $45.6 ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

In case you have $5,000 that is not required to pay bills or for any other contingencies, then picking stakes in either of ...

Get the latest healthcare stock updates, key pharma deals, and major legal developments impacting the S&P 500.

Stocks ended higher Friday as investors shook off concerns about the health of the banking sector and mulled comments from ...

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the price could be reached. Stocks of Novo Nordisk and Eli Lilly fell significantly ...

I go over 3 potential catalysts that could drive Eli Lilly's stock price up... or down. Read the full analysis here.

The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and ...

Eli Lilly shares are trading lower Friday, among other GLP-1 drug manufacturers, following Trump's comments that fat-loss ...